NASDAQ:ADVM   Adverum Biotechnologies, Inc.
Shrinking revenues and increasing costs, YOY: seekingalpha.com/sym...DVM/income-statement

Better products from much larger competitors: seekingalpha.com/new...te-ways-wet-amd-data

EV/EBITDA: -5
EPS: -1
Up 176% for the year

Might be worth targeting a 30% decline in the mid term? Thoughts?
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。